| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |